Testing for mutation status
ProcedureEGFR mutation test
NCT Number: NCT01185314
The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Research Site, Beijing, Beijing Municipality, China
A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
EGFR mutation test
Time frame: Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks.
Looking for future studies?
Notify MeAstraZeneca
Industry
A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
Acronym: PIONEER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07838532
Bronchial Neoplasms, Carcinoma, Bronchogenic
Nanjing, Jiangsu, China
View Trial DetailsNCT05312840
Bronchial Neoplasms, Carcinoma, Bronchogenic
Quzhou, Zhejiang, China
View Trial DetailsNCT01350817
Bronchial Neoplasms, Carcinoma, Bronchogenic
Angers, France
View Trial DetailsNCT05858736
Adenocarcinoma, Adnexal Diseases
Darlinghurst, New South Wales, Australia
View Trial Details